The Discounted Cash Flow (DCF) valuation of Epizyme Inc (EPZM) is (355.27) USD. With the latest stock price at 1.47 USD, the upside of Epizyme Inc based on DCF is -24268.2%.
Based on the latest price of 1.47 USD and our DCF valuation, Epizyme Inc (EPZM) is a sell. selling EPZM stocks now will result in a potential gain of 24268.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 8.8% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (728.31) - (237.96) | (355.27) |
| Upside | -49644.7% - -16287.8% | -24268.2% |